基于WTO通报的国际贸易中药品管控措施趋势分析与应对OA

This paper makes an in-depth analysis of the development trend of China's pharmaceutical export trade from 2019 to 2023.It points out that after a surge in export volume,it tends to stabilize with European and American markets leading exports and chemical agent exports steadily increasing.However,it faces the dual challenges of industrial chain transfer and tightening control.The paper systematically reviews the situation of drug control measures in the international market,with a focus on studying the characteristics of control measures in key export markets.Further analysis is conducted on the development trend of control measures,including an increase in the number of measures,tightening regulatory requirements,and digital technology driving the transformation of drug regulation towards intelligence.Finally,the paper proposes corresponding suggestions,including optimizing the drug regulatory system,improving export warning mechanisms,establishing a drug regulatory sandbox,standardizing digital traceability systems,and promoting digital trade platforms,aiming to provide strategic guidance and decision-making support for Chinese drug export enterprises.